Get the Stockscreener App
1.09
5.22%
-0.06
Skye Bioscience Inc stock is traded at $1.09, with a volume of 362.67K.
It is down -5.22% in the last 24 hours and down -28.29% over the past month.
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
See More
Previous Close:
$1.15
Open:
$1.15
24h Volume:
362.67K
Relative Volume:
0.46
Market Cap:
$34.94M
Revenue:
-
Net Income/Loss:
$-42.37M
P/E Ratio:
-1.02
EPS:
-1.0686
Net Cash Flow:
$-34.94M
1W Performance:
-9.17%
1M Performance:
-28.29%
6M Performance:
-49.77%
1Y Performance:
-67.46%
1-Day Range:
$1.09
$1.18
1-Week Range:
$1.09
$1.27
52-Week Range:
$1.09
$5.75
Skye Bioscience Inc Stock (SKYE) Company Profile
Name
Skye Bioscience Inc
Sector
Industry
Phone
(858) 410-0266
Address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Compare SKYE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.66 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.30 | 268.44M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.14 | 223.06M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.7287 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.74 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-06-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-06-25 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-15-25 | Initiated | Evercore ISI | Outperform |
| Feb-28-25 | Initiated | William Blair | Outperform |
| Sep-30-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-10-24 | Initiated | JMP Securities | Mkt Outperform |
| Jul-09-24 | Initiated | Craig Hallum | Buy |
| May-23-24 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-12-24 | Initiated | Oppenheimer | Outperform |
View All
Skye Bioscience Inc Stock (SKYE) Latest News
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - marketscreener.com
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
Levi & Korsinsky Notifies Skye Bioscience, Inc. Investors of a C - GuruFocus
SKYE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Skye Bioscience, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is Skye Bioscience Inc a good long term investmentGlobal Market Influence & Create Your Free Watchlist Instantly - earlytimes.in
Class Action Alert: Levi & Korsinsky Reminds Skye Bioscience, Inc. (SKYE) Investors of January 16, 2026 Deadline - ACCESS Newswire
SKYE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Skye Bioscience, Inc. to Contact the Firm Today! - ACCESS Newswire
Lost Money on Skye Bioscience, Inc. (SKYE)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Louisiana First News
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying - RTTNews
Investors SueWallSt as Skye Bioscience, Inc. Faces Securities Fraud Allegations - ACCESS Newswire
Investors SueWallSt as Skye Bioscience, Inc. Faces Securities Fraud Allegations (2025-12-10) - Seeking Alpha
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - GlobeNewswire
Skye Bioscience, Inc. Sued for Securities Law Violations – - GlobeNewswire
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Sui - GuruFocus
Lost Money on Skye Bioscience, Inc.(SKYE)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Sahm
Levi & Korsinsky Helps Retail Investors SueWallSt Over Alleged Fraud by Skye Bioscience, Inc - Stockhouse
January 16, 2026 Deadline: Join Class Action Lawsuit Against Skye Bioscience, Inc. (SKYE)Contact Levi & Korsinsky - ACCESS Newswire
SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Shareholders that lost money on Skye Bioscience, Inc. (SKYE) Urg - GuruFocus
Shareholders that lost money on Skye Bioscience, Inc. (SKYE) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation - PR Newswire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Skye Bioscience, Inc. Investors to Secure ... - Caledonian Record
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Skye - GlobeNewswire
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Se - GuruFocus
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit - Your Wyoming Link
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Skye Bioscience, Inc. (SKYE) Investors of January 16, 2026 Deadline - ACCESS Newswire
SKYE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Skye Bioscience, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will Skye Bioscience Inc. (09R) stock profit from fiscal stimulusQuarterly Portfolio Summary & High Accuracy Buy Signal Tips - Newser
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing - Your Wyoming Link
Skye Bioscience, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates - GuruFocus
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Skye Bioscience, Inc. Investors - GlobeNewswire
Shareholders of Skye Bioscience, Inc. Should Contact The Gross L - GuruFocus
Shareholders of Skye Bioscience, Inc. Should Contact The Gross Law Firm Before January 16, 2026 to Discuss Your RightsSKYE - PR Newswire
Will Skye Bioscience Inc. (09R) stock gain from lower interest ratesJuly 2025 Technicals & Long-Term Safe Investment Ideas - Newser
Bragar Eagel & Squire, P.C. Urges DeFi, Skye Bioscience, - GlobeNewswire
SueWallSt With Us: Levi & Korsinsky Notifies Shareholders of Class Action Against Skye Bioscience, Inc - ACCESS Newswire
Investors in Skye Bioscience, Inc. Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your RightsSKYE - WV News
SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - GlobeNewswire
You might want to take a look at Skye Bioscience Inc (SKYE) now - Setenews
SKYE Class Action Reminder: Skye Bioscience, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit - Lelezard
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience - Newsfile
SKYE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Skye Bioscience, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Skye Bioscience, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationSKYE - Lelezard
Is Skye Bioscience Inc. (09R) stock resilient in recession scenarios2025 Short Interest & Safe Swing Trade Setup Alerts - Newser
Is Skye Bioscience Inc. (09R) stock prepared for digital transitionGap Down & Long-Term Capital Growth Strategies - Newser
Skye Bioscience, Inc. (NASDAQ: SKYE) Securities Class - GlobeNewswire
January 16, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SKYE - GlobeNewswire
What analysts say about Skye Bioscience Inc 09R stockHigh Dividend Yield Stocks & Low Risk Trading Portfolio - earlytimes.in
Skye Bioscience Inc Stock (SKYE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Skye Bioscience Inc Stock (SKYE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schwab Andrew J. | Director |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 22 '25 |
Sale |
3.42 |
170,449 |
582,936 |
57,493 |
| 5AM Partners VII, LLC | 10% Owner |
Aug 21 '25 |
Sale |
3.57 |
60,956 |
217,613 |
63,963 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):